Tender detail
Amgros 2027 1.1207.a
Summary
The tender concerns framework agreements for medicines in several lots, including gadoteric acid, gadoteridol, gadobutrol, gadoxetic acid, gadopiclenol, gadoquatrane and sulfur hexafluoride phospholipid microspheres. The bidder may submit an offer for one, several or all lots. The framework agreements are non-exclusive and are intended to supply hospital pharmacies; there is no purchase obligation. The exact exclusion, qualification and compliance requirements must be checked in the tender documents.
More tender information after sign-in
The public view shows key tender details. Sign in to open official links, documents and AI tender support.